Sumitomo Mitsui Trust Holdings Inc. Acquires 7,744 Shares of DENTSPLY SIRONA Inc (XRAY)

Sumitomo Mitsui Trust Holdings Inc. raised its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 883,212 shares of the medical instruments supplier’s stock after purchasing an additional 7,744 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $43,798,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in XRAY. Harel Insurance Investments & Financial Services Ltd. purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. Private Capital Group LLC lifted its stake in shares of DENTSPLY SIRONA by 105.3% during the fourth quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 359 shares during the period. Pinnacle Bank purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. Truehand Inc purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $27,000. Finally, Enlightenment Research LLC purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $30,000. 91.69% of the stock is currently owned by institutional investors.

In other DENTSPLY SIRONA news, SVP Daniel P. Key acquired 3,697 shares of the company’s stock in a transaction dated Tuesday, May 7th. The stock was bought at an average price of $54.68 per share, with a total value of $202,151.96. Following the completion of the transaction, the senior vice president now directly owns 9,024 shares of the company’s stock, valued at $493,432.32. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Gregory T. Lucier acquired 10,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The stock was acquired at an average cost of $53.60 per share, with a total value of $536,000.00. Following the transaction, the director now directly owns 10,000 shares of the company’s stock, valued at $536,000. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 123,922 shares of company stock worth $6,790,905. 0.62% of the stock is currently owned by insiders.

Several brokerages recently issued reports on XRAY. Guggenheim began coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, April 17th. They set a “neutral” rating and a $54.00 price objective on the stock. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Monday, May 6th. HC Wainwright reissued a “neutral” rating and set a $55.00 price objective (up previously from $49.00) on shares of DENTSPLY SIRONA in a research note on Monday, May 6th. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 price objective on the stock in a research note on Monday, May 6th. Finally, William Blair raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $56.71 price objective on the stock in a research note on Monday, March 18th. Eight analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $53.55.

NASDAQ:XRAY opened at $53.75 on Monday. The company has a current ratio of 2.06, a quick ratio of 1.35 and a debt-to-equity ratio of 0.33. The company has a market cap of $12.58 billion, a price-to-earnings ratio of 26.74, a P/E/G ratio of 2.00 and a beta of 1.11. DENTSPLY SIRONA Inc has a fifty-two week low of $33.93 and a fifty-two week high of $55.88.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.10. The company had revenue of $946.20 million for the quarter, compared to the consensus estimate of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. DENTSPLY SIRONA’s revenue was down 1.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.45 earnings per share. On average, equities analysts predict that DENTSPLY SIRONA Inc will post 2.34 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.0875 per share. The ex-dividend date is Thursday, June 27th. This represents a $0.35 dividend on an annualized basis and a yield of 0.65%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 17.41%.

ILLEGAL ACTIVITY WARNING: “Sumitomo Mitsui Trust Holdings Inc. Acquires 7,744 Shares of DENTSPLY SIRONA Inc (XRAY)” was originally reported by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.wkrb13.com/2019/05/27/sumitomo-mitsui-trust-holdings-inc-acquires-7744-shares-of-dentsply-sirona-inc-xray.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: Forex

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.